Department of Cardiovascular Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Division of Regeneration and Medicine, Hiroshima University Hospital.
J Atheroscler Thromb. 2019 Aug 1;26(8):688-696. doi: 10.5551/jat.RV17035. Epub 2019 Jul 2.
Bilirubin is a fundamental metabolic end product of heme degradation. Despite acting as a cytotoxic metabolite at high concentrations, bilirubin at physiological concentrations has antioxidant effects, such as scavenging reactive oxygen species, leading to a decrease in oxidative stress. Endothelial dysfunction is an early feature of and plays an important role in the development and progression of atherosclerosis, leading to cardiovascular complications. One mechanism of endothelial dysfunction is an increase in oxidative stress, by which the bioavailability of nitric oxide is decreased. Therefore, bilirubin is expected to improve endothelial function, to inhibit the progression of atherosclerosis, and to reduce cardiovascular complications by inactivating oxidative stress through its antioxidant effects. In this review, we will focus on the clinical associations of the antioxidant bilirubin with endothelial function and cardiovascular complications.
胆红素是血红素降解的基本代谢终产物。尽管在高浓度时作为细胞毒性代谢物起作用,但胆红素在生理浓度下具有抗氧化作用,例如清除活性氧,从而降低氧化应激。内皮功能障碍是动脉粥样硬化发生和发展的早期特征,并发挥重要作用,导致心血管并发症。内皮功能障碍的一个机制是氧化应激增加,从而降低了一氧化氮的生物利用度。因此,胆红素有望通过其抗氧化作用来改善内皮功能,抑制动脉粥样硬化的进展,并减少心血管并发症。在这篇综述中,我们将重点讨论抗氧化胆红素与内皮功能和心血管并发症的临床关联。